Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Sorting through new biomarkers.

Wood FO, de Lemos JA.

Curr Cardiol Rep. 2008 Jul;10(4):319-26.

PMID:
18611367
2.

[Redefinition of myocardial infarction--relevance of biomarkers].

Weber M, Hamm C.

Herz. 2008 Mar;33(2):115-21. doi: 10.1007/s00059-008-3103-7. Review. German.

PMID:
18344030
3.

Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.

Palazzuoli A, Iovine F, Gallotta M, Nuti R.

Minerva Cardioangiol. 2007 Aug;55(4):491-6. Review.

PMID:
17653025
4.

Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes.

de Lemos JA, Morrow DA.

Rev Cardiovasc Med. 2003;4 Suppl 4:S37-46. Review.

PMID:
14564227
5.

Time to treatment and acute coronary syndromes: bridging the gap in rapid decision making.

Peacock WF.

Rev Cardiovasc Med. 2010;11 Suppl 2:S45-50. Review.

PMID:
20700102
6.

Markers of acute coronary syndrome in emergency room.

Loria V, Dato I, De Maria GL, Biasucci LM.

Minerva Med. 2008 Oct;99(5):497-517. Review. English, Italian.

PMID:
18971915
7.

Cardiac biomarkers in acute coronary syndromes: a review.

Amodio G, Antonelli G, Di Serio F.

Curr Vasc Pharmacol. 2010 May;8(3):388-93. Review.

PMID:
19485924
8.
9.

Biomarkers, C-reactive proteins and statins in acute coronary syndromes.

Ray KK.

Fundam Clin Pharmacol. 2007 Nov;21 Suppl 2:31-3. Review.

PMID:
18001319
10.

Biomarkers in acute coronary syndrome and percutaneous coronary intervention.

Searle J, Danne O, Müller C, Mockel M.

Minerva Cardioangiol. 2011 Jun;59(3):203-23. Review.

PMID:
21516070
11.

Natriuretic peptides in the prognosis and management of acute coronary syndromes.

de Lemos JA, Peacock WF, McCullough PA.

Rev Cardiovasc Med. 2010;11 Suppl 2:S24-34. Review.

PMID:
20700099
12.

Biochemical markers in acute coronary syndrome.

Ramasamy I.

Clin Chim Acta. 2011 Jul 15;412(15-16):1279-96. doi: 10.1016/j.cca.2011.04.003. Epub 2011 Apr 8. Review.

PMID:
21501603
13.

Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications.

Farmakis D, Filippatos G, Tubaro M, Peacock WF, Disomma S, Mueller C, Kremastinos DT, Maisel AS.

Congest Heart Fail. 2008 Jul-Aug;14(4 Suppl 1):25-9. Review.

PMID:
18772630
14.

Role of biomarkers in risk stratification of acute coronary syndrome.

Nagesh CM, Roy A.

Indian J Med Res. 2010 Nov;132:627-33. Review.

15.

Current trends in diagnostic biomarkers of acute coronary syndrome.

Moe KT, Wong P.

Ann Acad Med Singapore. 2010 Mar;39(3):210-5. Review.

16.

[Biomarkers in cardiology--state of the art 2007].

Mair J.

Wien Med Wochenschr. 2007 Feb;157(3-4):48-56. Review. German.

PMID:
17340059
17.

[Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].

Trepels T, Zeiher AM, Fichtlscherer S.

Herz. 2004 Dec;29(8):769-76. Review. German.

PMID:
15599673
18.

Defining a role for novel biomarkers in acute coronary syndromes.

Bonaca MP, Morrow DA.

Clin Chem. 2008 Sep;54(9):1424-31. doi: 10.1373/clinchem.2008.105387. Epub 2008 Jul 18. Review.

19.

The influence of exercise upon cardiac biomarkers: a practical guide for clinicians and scientists.

Shave R, George K, Gaze D.

Curr Med Chem. 2007;14(13):1427-36. Review.

PMID:
17584054
20.

Acute coronary syndrome: emerging tools for diagnosis and risk assessment.

Scirica BM.

J Am Coll Cardiol. 2010 Apr 6;55(14):1403-15. doi: 10.1016/j.jacc.2009.09.071. Review.

Supplemental Content

Support Center